Pilot Study Evaluating BreathAlert Device for Monitoring Apnea in Infants and Children at Risk

What this Trial Is About

Researchers are evaluating a device called BreathAlert, developed by Rice University in collaboration with clinicians at Queen Elizabeth Central Hospital, to monitor apnea in infants and children at risk. This observational study aims to assess BreathAlerts ability to detect respiration and apneic episodes by comparing its performance to traditional vital sign monitors, which include measurements such as temperature, heart rate, EKG, respiratory rate, SPO2, and impedance pneumography. During the study, the BreathAlert device, a low-cost battery-powered respiratory rate and apnea monitor, is attached to patients in the neonatal or pediatric ward who are at risk for apnea or require respiratory rate monitoring. Data is collected simultaneously from both BreathAlert and standard vital signs monitors while the patient is being observed. Participants will have the BreathAlert device attached while they are at risk for apnea, and researchers will collect data from both the device and existing monitors. The main outcome measured is the accuracy of BreathAlert over a maximum period of one week. The study involves patients from newborns up to 17 years old, with caregiver consent required, and continues until study completion in June 2028.

Clinical Assessment of the BreathAlert Device in Monitoring Apneic Episodes